All In Biotech

Drug Trial Radar · NCT02560584

A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting

A Prospective, Open, Comparative, Within Patient Controlled Multicenter Phase 3 Study of Blue Light Cystoscopy With Cysview and White Light Cystoscopy Using KARL STORZ D-Light C PDD Flexible Videoscope System in Detection of Bladder Cancer in Patients With Bladder Cancer

Last checked: Nov 20, 2026Latest source record: Jul 2, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

304

Actual

Start

Oct 1, 2015

Primary completion

Apr 5, 2017

Study completion Apr 5, 2017

Sponsor

Lead sponsor
PhotocureIndustry
Sponsor type
Industry
Collaborators
KARL STORZ Endoscopy-America, Inc.
First posted
Sep 25, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate if blue light cystoscopy with Cysview improves detection of tumors in patients with bladder cancer during surveillance cystoscopy, using the KARL STORZ D-Light C PDD Flexible Videoscope System. Another purpose is to investigate if Cysview and blue light is safe and effective when used repeatedly.

Conditions

  • Bladder Cancer

Interventions

  • Hexaminolevulinate hydrochlorideDrug

    Instillation in bladder

  • KARL STORZ D-Light C PDD Flexible Videoscope SystemDevice

    Cystoscopy procedure

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Patients With Histologically Confirmed Malignancy Where Malignancy is Only Detected With Blue Light Cystoscopy With Cysview and Not White Light CystoscopyTime frame: At time of cystoscopy procedure

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • USC Norris Comprehensive Cancer Center

    Los Angeles, California

  • University of Chicago Medical Center

    Chicago, Illinois

  • University of Iowa

    Iowa City, Iowa

  • Johns Hopkins University

    Baltimore, Maryland

  • University of Minnesota

    Minneapolis, Minnesota

  • NYU Langone Urology Associates

    New York, New York

  • Columbia University Medical Center

    New York, New York

  • Montefiore Medical Center

    The Bronx, New York

  • University of North Carolina, Department of Urology

    Chapel Hill, North Carolina

  • Ohio State University The James Cancer Hospital

    Columbus, Ohio

  • University of Oklahoma-Stephenson Cancer Center

    Oklahoma City, Oklahoma

  • Thomas Jefferson University

    Philadelphia, Pennsylvania

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • UT Southwestern Medical Center

    Dallas, Texas

  • MD Anderson Cancer Center

    Houston, Texas

  • Michael E. DeBakey VA Medical Center

    Houston, Texas

  • University of Wisconsin

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.